Navigation Links
Cethromycin Shown Effective Against Anthrax in Study

Advanced Life Sciences Achieves Key Endpoint in Primate Study

CHICAGO, May 02, 2007 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. today announced that its novel respiratory antibiotic, Cethromycin, was shown to be effective in preventing inhalation anthrax infection. This conclusion was reached from a primate study where a 30-day course of oral Cethromycin was 100% protective against a lethal dose of inhaled anthrax as compared to the standard of care, Cipro(R) (ciprofloxacin), which demonstrated 90% protection.

"We felt confident going into the primate study because of Cethromycin's potent activity against over 30 strains of anthrax, yet the results have exceeded our expectations," said Dr. Michael T. Flavin, Chief Executive Officer for Advanced Life Sciences. "We believe that Cethromycin's unique antibacterial properties differentiate it from other antibiotics and, if approved by the FDA, may allow it to become a useful tool in the treatment of infections such as anthrax."

Cethromycin was recently granted Orphan Drug designation by the FDA for the prophylactic treatment of inhalation anthrax and is being developed in collaboration with U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and the NIH's National Institute of Allergy and Infectious Disease (NIAID). Cethromycin, which has been tested in over 4,400 human subjects, is also in pivotal Phase III trials for the treatment of community acquired pneumonia (CAP). The Company expects to report data from the CAP program in June of this year.

"With emerging bacterial resistance, both natural and engineered, there is a critical need for new antibiotics that work differently than currently available therapies to protect against anthrax," continued Dr. Flavin. "To our knowledge, there are no other antibiotics in late-stage development to address this need. Based on the human safety and animal efficacy dat
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
2. Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
3. RTA 402 Shown to Protect Animals Against Toxicities of Standard Cancer Treatments
4. Gabapentin Shown Effective for Fibromyalgia Pain
5. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
6. CEL-SCIS CEL-1000 Shown to Significantly Enhance Immune Response Against Avian Flu Antigen in Animals
7. Efficacy and Safety Profile of Basileas Alitretinoin for Severe Refractory Chronic Hand Eczema Confirmed by Data Shown at European Dermatology Congress
8. Innovative Cancer Drug MabThera Again Shown To Improve Survival Rates In Patients With Lymphoma
9. RTA 402 Shown to Inhibit STAT3 in Animal Model and Holds Significant Promise for Treating Breast Cancer
10. Accelreon Pharmas ACE-031Shown to Increase Muscle Mass in Preclinical Studies
11. CEL-SCIs Cel-1000 Shown to Significantly Enhance Immune Response Against Hepatitis B Antigen in Animals
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cethromycin Shown Effective Against Anthrax Study
(Date:8/22/2014)... MC Medical, a subsidiary of Mitsubishi Corporation (MCM), and Minimally ... medical device company, have formally agreed to an exclusive ... in Japan . It is anticipated that ... in the latter half of 2015. ... in endoscopic surgery market in Japan . ...
(Date:8/22/2014)... , Aug. 22, 2014  Mark Riccio, ... (CT) imaging facility, is using the online crowd-funding ... even 5D imaging to researchers and would-be superheros ... asks "What would YOU do if you had ... to researchers and explorers everywhere, from elementary through ...
(Date:8/22/2014)... 22, 2014  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today ... units of common stock and warrants at a price ... million, prior to deducting underwriting discounts and commissions and ... warrants are immediately separable and will be issued separately.  ... trading on The NASDAQ Stock Market under the ticker ...
Breaking Medicine Technology:MC Medical agrees to be the exclusive distributor of FloShield products in Japan 2Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4
(Date:8/22/2014)... Vegas, NV (PRWEB) August 22, 2014 ... teaches readers how they can use natural methods to ... years has caught the attention of Shane Michaels, prompting ... a condition that affects the skin, it can still ... from it,” reports Michaels. “The intense itching and pain ...
(Date:8/22/2014)... receptor (EGFR) mutations found in the circulating free tumor ... lung cancer (NSCLC) patients correlates well with the EGFR ... kinase inhibitor (TKI) therapy is approved for EGFR activating ... for determining mutation status is with DNA derived directly ... available. A more abundant and less invasive source of ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Advancements ... for some clinical applications due to their cost-effectiveness, ... emerging innovations in ultrasound, such as the evolution ... expected to keep the market moving throughout 2014 ... mobility can enhance not only the point-of-care (POC) ...
(Date:8/22/2014)... NJ (PRWEB) August 22, 2014 ... leading specialist in Internal Medicine, Geriatrics, Hospice and ... network, CarePoint Health Medical Group. Their system welcomes ... skilled and experienced physicians comprise CarePoint Health Medical ... practices in Hudson County, representing a wide range ...
(Date:8/22/2014)... 22, 2014. A new study of self-awareness ... multiple sclerosis (MS) may be able to improve ... was epublished ahead of print on July 2 ... Hali Griswold, Nancy D. Chiaravalloti & John DeLuca: ... multiple sclerosis doi: 10.3233/NRE-141113). Self-awareness is one,s ability ...
Breaking Medicine News(10 mins):Health News:Beat Eczema: Review Exposes Susan Clark’s Guide to Curing Eczema Naturally 2Health News:High concordance between EGFR mutations from circulating-free tumor DNA and tumor tissue in non-small cell lung cancer 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 3Health News:Dr. Reisner Joins CarePoint Health Medical Group 2Health News:Kessler Foundation study of self-awareness in MS has implications for rehabilitation 2
... Liquids have set out to warm up chilly Boston bus riders by heating ten bus shelters in ... the following locations: , , , 666 ... 510 Boylston Square @ Clarendon Street , ... @ Huntingdon , , , , ...
... cognition tests, study found , , MONDAY, Jan. 26 (HealthDay News) ... glucose (sugar) levels may be linked to lower brain function, ... with higher levels of hemoglobin A1C (a measure of average ... worse results while doing cognitive tasks that tested memory, speed ...
... months most susceptible, analysis finds , , MONDAY, Jan. 26 (HealthDay ... syndrome (SIDS) in the United States has declined, the rate ... a new study reports. , Such deaths have been most ... to the study, published in the February issue of ...
... ,extreme, winter sports by following these safety tipsROSEMONT, Ill., ... ("x-treme") sports can be a fun way to get ... televised events such as the X Games have led ... racing and jumping, snowboarding, snowmobiling, snow biking, and ice ...
... Brighter smiles await,children in Georgia as the Colgate-Palmolive ... Program to the Smyrna and Marietta Big,Lots stores on ... http://www.newscom.com/cgi-bin/prnh/20011026/BIGLOTSLOGO ) , ... van and its team,of dental professionals will provide free ...
... SpectraScience, Inc. (OTC Bulletin Board: SCIE), a San ... the status of its business.Jim Hitchin, SpectraScience,s CEO, said, ... progress on all business fronts. We understand, however, that ... important to provide our shareholders with a greater level ...
Cached Medicine News:Health News:It's Cold Outside! Warm Up in Select Downtown Boston Heated Bus Shelters Courtesy of TYLENOL(r) Warming Liquids 2Health News:Higher Blood Sugar Could Impair Thinking 2Health News:More Accidental Infant Deaths Blamed on Suffocation in Bed 2Health News:More Accidental Infant Deaths Blamed on Suffocation in Bed 3Health News:More Accidental Infant Deaths Blamed on Suffocation in Bed 4Health News:'X-Tremely' Dangerous Sports 2Health News:'X-Tremely' Dangerous Sports 3Health News:Colgate's Bright Smiles, Bright Futures Program Brings Free Children's Dental Screenings to Atlanta Area Big Lots Stores 2Health News:SpectraScience Announces Business Update 2Health News:SpectraScience Announces Business Update 3
... is the most common cause ... 5% of pediatric visits and ... under 5 years. ImmunoSTAT! Rotatvirus ... rule in or rule out ...
... delivers 100% specificity and 100% PPV ... With as many as one-fourth ... this assay provides a test & ... detection and treatment while reducing overall ...
Shielding's Wrap-Around Apron is designed for front and back protection. This apron features extra wide shoulders distributing weight over a greater area to reduce fatigue....
Shielding's Velcro Adjustable Apron has two velcro flaps which aid in relieving weight off the shoulders. Its comfortable fit is attained by varying the position of flaps....
Medicine Products: